Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion type Assertion NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_head.
- NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion description "[We hypothesized that genetic variability in genes encoding enzymes metabolizing glycolytic intermediates produced in excess under hyperglycemic conditions [i.e., transketolase (TKT), transaldolase, TKT-like protein 1, fructosamine 3-kinase (FN3K), glyoxalase 1 and glucose-6-phosphate dehydrogenase] could influence progression of diabetic nephropathy (DN) and diabetes-related morbidity and mortality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_provenance.
- NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion evidence source_evidence_literature NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_provenance.
- NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion SIO_000772 23492569 NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_provenance.
- NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion wasDerivedFrom befree-2016 NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_provenance.
- NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_assertion wasGeneratedBy ECO_0000203 NP1060401.RA2iJ-dO8oK0sR6An1QZj4SN_EtX5Dy-MXYzym2-zkUS8130_provenance.